Please assess the completion status of the following clinical trial:

Trial Title: Frequency Specific Microcurrent for the Treatment of Diastasis Recti

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
\*\*Patients must be able to get care at Nellis Air Force Base (a military installation) in order to participate in this study\*\*~Inclusion Criteria:~* Active Duty and DoD beneficiary Postpartum Females (12 hours to 24 hours) with Diastasis Rectus Abdominus (DRA) pain~* Aged 18 years or older~* Singleton gestation/delivered (one baby carried and born)~* Vaginal delivery~* Nulliparous (first pregnancy) or multiparous (more than one pregnancy in the past)~Exclusion Criteria:~* less than 18 years of age~* females greater than 24 hours post-partum~* Medical history to include pacemaker~* History of arrhythmia~* Transplant status~* Insulin pump~* Pain pump~* Active cancer~* Inability to measure IRD~* Delivery via caesarean section~* Operative vaginal delivery (vacuum or forceps)~* 3rd or 4th degree vaginal laceration

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Sham (fake) microcurrent therapy (Type: SHAM_COMPARATOR): Sham (fake) microcurrent therapy (placing the microcurrent pads on the patient and turning the microcurrent box on placebo mode )
- Frequency specific microcurrent therapy (Type: EXPERIMENTAL): Frequency specific microcurrent therapy (100-300μA microccurrent amps) with Diastasis Recti Repair protocol (8),

Based on this trial design, predict the completion outcome and termination type (if applicable).